Cancer vaccines based on whole-tumor lysate or neoepitopes with validated HLA binding outperform those with predicted HLA-binding affinity

por Fritah, Hajer, Graciotti, Michele, Lai-Lai Chiang, Cheryl, Huguenin- Bergenat, Anne-Laure, Petremand, Rémy, Ahmed, Ritaparna, Guillaume, Philippe, Schmidt, Julien, Stevenson, Brian J., Gfeller, David, Harari, Alexandre, Kandalaft, Lana E.
Publicado 2023

Personalized cancer vaccine strategy elicits polyfunctional T cells and demonstrates clinical benefits in ovarian cancer

por Tanyi, Janos L., Chiang, Cheryl L.-L., Chiffelle, Johanna, Thierry, Anne-Christine, Baumgartener, Petra, Huber, Florian, Goepfert, Christine, Tarussio, David, Tissot, Stephanie, Torigian, Drew A., Nisenbaum, Harvey L., Stevenson, Brian J., Guiren, Hajer Fritah, Ahmed, Ritaparna, Huguenin-Bergenat, Anne-Laure, Zsiros, Emese, Bassani-Sternberg, Michal, Mick, Rosemarie, Powell, Daniel J., Coukos, George, Harari, Alexandre, Kandalaft, Lana E.
Publicado 2021

Author Correction: Personalized cancer vaccine strategy elicits polyfunctional T cells and demonstrates clinical benefits in ovarian cancer

por Tanyi, Janos L., Chiang, Cheryl L.-L., Chiffelle, Johanna, Thierry, Anne-Christine, Baumgartener, Petra, Huber, Florian, Goepfert, Christine, Tarussio, David, Tissot, Stephanie, Torigian, Drew A., Nisenbaum, Harvey L., Stevenson, Brian J., Guiren, Hajer Fritah, Ahmed, Ritaparna, Huguenin-Bergenat, Anne-Laure, Zsiros, Emese, Bassani-Sternberg, Michal, Mick, Rosemarie, Powell, Daniel J., Coukos, George, Harari, Alexandre, Kandalaft, Lana E.
Publicado 2021